Table 2 Associations (univariable analysis) between central corneal thickness and ocular parameters in the Ural Eye and Medical Study.
Parameter | Interval | Standardized regression coefficient beta | Non- standardized regression coefficient B | 95% confidence interval of B | P-Value |
|---|---|---|---|---|---|
Refractive error, spherical equivalent | Dioptres | 0.02 | 0.25 | 0.14, 0.23 | 0.21 |
Refractive error, cylindrical value | Dioptres | 0.02 | 0.75 | −0.37, 1.86 | 0.19 |
Axial length | mm | 0.04 | 1.32 | 0.52, 2.12 | 0.001 |
Corneal refractive power | Dioptres | −0.13 | −2.62 | −3.16, −2.08 | <0.001 |
Corneal volume | mm3 | 0.73 | 5.99 | 5.84, 6.14 | <0.001 |
Anterior chamber depth | mm | −0.01 | −0.50 | −2.28, 1.29 | 0.59 |
Anterior chamber volume | µL | −0.08 | −0.08 | −0.10, −0.05 | <0.001 |
Anterior chamber angle | Degree | −0.07 | −0.35 | −0.48, −0.23 | <0.001 |
Lens thickness | mm | −0.01 | −1.09 | −3.24, 1.07 | 0.32 |
Nuclear cataract degree | Grade | −0.02 | −0.71 | −1.63, 0.22 | 0.14 |
Nuclear cataract, prevalence | No / Yes | −0.01 | −0.80 | −2.71, 1.11 | 0.41 |
Cortical cataract, degree | Percentage | −0.04 | −0.13 | −0.23, −0.03 | 0.008 |
Cortical cataract, prevalence | No / Yes | −0.04 | −4.19 | −6.97, −1.42 | 0.003 |
Subcapsular cataract, degree | Percentage | 0.01 | 0.16 | −0.22, 0.55 | 0.41 |
Subcapsular cataract, prevalence | No / Yes | 0.001 | 0.43 | −11.8, 12.6 | 0.95 |
Fundus tessellation, macula region | Grade | 0.001 | 0.03 | −1.04, 1.10 | 0.95 |
Fundus tessellation, peripapillary region | Grade | −0.006 | −0.19 | −1.10, 0.72 | 0.68 |
Intraocular pressure, before Mydriasis | mmHg | 0.34 | 2.95 | 2.74, 3.16 | <0.001 |
Intraocular pressure, after Mydriasis | mmHg | 0.32 | 2.72 | 2.48, 2.96 | <0.001 |
Intraocular pressure, difference “after Mydriasis” minus “before mydriasis” | mmHg | −0.04 | −0.43 | −0.78, −0.07 | 0.02 |
Retinal thickness (total), fovea | µm | 0.01 | 0.01 | −0.01, 0.02 | 0.46 |
Retinal thickness (total), 300 µm temporal to the fovea | µm | 0.03 | 0.03 | 0.002, 0.05 | 0.03 |
Retinal thickness (total), 300 µm nasal to the fovea | µm | 0.02 | 0.02 | −0.01, 0.04 | 0.14 |
Retinal nerve fibre layer thickness, peripapillary | µm | 0.03 | 0.05 | −0.003, 0.10 | 0.07 |
Pterygium, prevalence | No / Yes | −0.03 | −8.31 | −15.1, 1.61 | 0.02 |
Pseudoexfoliation, | No / Yes | −0.01 | −0.94 | −5.74, 3.86 | 0.70 |
Glaucoma, prevalence | No / Yes | 0.01 | 1.82 | 2.79, 6.43 | 0.44 |
Glaucoma stage | 0–5 | −0.01 | −0.71 | −2.64, 1.21 | 0.47 |
Open-angle glaucoma, prevalence | No / Yes | −0.01 | −1.90 | −7.37, 3.56 | 0.50 |
Angle-closure glaucoma, prevalence | No / Yes | 0.03 | 10.9 | 2.38, 19.3 | 0.01 |
Diabetic retinopathy, prevalence | No / Yes | 0.04 | 9.56 | 2.52, 16.6 | 0.008 |
Diabetic retinopathy, ETDRS grading | Scale | 0.03 | 0.22 | −0.03, 0.46 | 0.08 |
Myopic maculopathy, stage | 0–4 | −0.01 | −0.80 | −3.37, 1.78 | 0.55 |
Age-related macular degeneration, early stage, prevalence | No / Yes | −0.01 | −1.56 | −5.26, 2.15 | 0.41 |
Age-related macular degeneration, intermediate stage, prevalence | No / Yes | 0.002 | 0.40 | −4.10, 4.91 | 0.86 |
Age-related macular degeneration, late stage, prevalence | No / Yes | −0.01 | −1.23 | −7.24, 4.79 | 0.69 |
Age-related macular degeneration, reticular pseudodrusen, prevalence | No / Yes | −0.04 | −6.18 | −10.5, −1.87 | 0.005 |
Age-related macular degeneration, any stage, prevalence | No / Yes | −0.01 | −1.41 | −4.47, 1.67 | 0.37 |
Dry eye, Schirmer test | mm | 0.03 | 0.15 | 0.02, 0.29 | 0.03 |
Meibomian gland dysfunction | Grade 0–4 | −0.02 | −0.67 | −1.70, 0.36 | 0.20 |
Visual acuity, best corrected | logMAR | −0.01 | −1.00 | −3.30, 1.30 | 0.39 |
